Topiramate for the Treatment of Methamphetamine Dependence - 1

Methamphetamine Clinical Trial

Official title:
Phase 2, Double-Blind, Placebo-Controlled Trial of Topiramate for the Treatment of Methamphetamine Dependence

Status Completed

Clinical Trial Summary

The purpose of this study is to assess the efficacy and safety of topiramate as compared to placebo in reducing methamphetamine use in subjects with methamphetamine dependence.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment

Related Conditions & MeSH terms

Methamphetamine

Clinical Trial Details

NCT number	NCT00345371
Study type	Interventional
Source	National Institute on Drug Abuse (NIDA)
Contact
Status	Completed
Phase	Phase 2
Start date	April 2006
Completion date	December 2007

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00135785` - Effectiveness of Bupropion Combined With Behavioral Therapy for Treating Methamphetamine Dependence - 2	Phase 2
Completed	`NCT01723384` - Intermittent Naltrexone Among Polysubstance Users	Phase 2
Completed	`NCT04544124` - Delivering Contingency Management in Outpatient Addiction Treatment	N/A
Completed	`NCT00833443` - Study of Medical Treatment for Methamphetamine Addiction	Phase 2
Completed	`NCT01174654` - Development of a Methamphetamine Early Intervention	Phase 1/Phase 2